Jump to main content
Jump to site search

Chemical Communications

Urgent high quality communications from across the chemical sciences.


Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

Corresponding authors
Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK
E-mail: L.H.Patterson@Bradford.ac.uk
Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, London, UK
School of Pharmacy, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK
Chem. Commun., 2011,47, 12062-12064

DOI: 10.1039/C1CC15638A
Received 12 Sep 2011, Accepted 04 Oct 2011
First published online 14 Oct 2011
Please wait while Download options loads

Supplementary Info